A phase II pilot trial to evaluate the efficacy of treatment with Pegilate G-CSF in a group of elderly patients AML without chemotherapy indications.
Phase of Trial: Phase II
Latest Information Update: 11 Jul 2011
At a glance
- Drugs Pegfilgrastim (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 11 Jul 2011 New trial record